nature neurOSCIenCe a r t I C l e S DA has long been known to regulate diverse brain functions, including movement coordination, reward, learning and memory. Dysfunction in DA systems is associated with a variety of neurological disorders, such as psychiatric diseases, attention deficit/hyperactivity disorder and Parkinson's disease. The impact of dysfunction of DA system on health indicates the importance of maintaining DA functionality through homeostatic mechanisms that are largely dependent on the delicate balance between synthesis, storage, release, reuptake and metabolism. DA signaling is highly regulated in a temporal and spatial fashion. After release into the synaptic cleft, DA is quickly removed by DAT, which is central to terminating DA signaling and maintaining DA homeostasis in single DA neuron terminals. As such, DAT −/− (Slc6a3 −/− ) mice display dramatic DA depletion in tissue stores and hyperlocomotion 1 . DAT is also known as the primary target for the addictive drugs cocaine and amphetamine. Thus, an understanding of the molecular mechanisms underlying control of DAT expression and activity is helpful for advancing our understanding of DA signaling and DAT-associated brain disorders.
a r t I C l e S DA has long been known to regulate diverse brain functions, including movement coordination, reward, learning and memory. Dysfunction in DA systems is associated with a variety of neurological disorders, such as psychiatric diseases, attention deficit/hyperactivity disorder and Parkinson's disease. The impact of dysfunction of DA system on health indicates the importance of maintaining DA functionality through homeostatic mechanisms that are largely dependent on the delicate balance between synthesis, storage, release, reuptake and metabolism. DA signaling is highly regulated in a temporal and spatial fashion. After release into the synaptic cleft, DA is quickly removed by DAT, which is central to terminating DA signaling and maintaining DA homeostasis in single DA neuron terminals. As such, DAT −/− (Slc6a3 −/− ) mice display dramatic DA depletion in tissue stores and hyperlocomotion 1 . DAT is also known as the primary target for the addictive drugs cocaine and amphetamine. Thus, an understanding of the molecular mechanisms underlying control of DAT expression and activity is helpful for advancing our understanding of DA signaling and DAT-associated brain disorders.
The function of DAT can be regulated through redistribution of the protein to or from the cell surface. Much has been learned in recent years about the mechanisms underlying DAT trafficking, which has been characterized most thoroughly by studying DAT-interacting proteins in culture. A set of proteins that mediate DAT trafficking, such as protein kinase C (PKC) 2, 3 , PICK1 (ref. 4) , Hic-5 (ref. 5) , calcium/calmodulin-dependent kinase II (ref. 6 ), flotilin-1 (ref. 7) and Rin GTPase 8 , has been identified. Recently, S-palmitoylation has been identified as a regulator of DAT kinetics, degradation and PKC-dependent regulation 9 , indicating the complexity in regulation of DAT function. Although these studies have provided much insight into the protein machinery involved in DAT trafficking, most have been performed predominantly in heterologous systems. As a consequence, the functional significance of many observations has not been evaluated in the brain in vivo and the specific mechanisms of DAT internalization remain to be fully defined.
Recently, Vav2 was described as potential mediator of endocytosis 10, 11 . Vav2 belongs to the VAV family of oncogene proteins with guanine nucleotide exchange factor (GEF) activity for small G proteins of the Rho family. The Vav family comprises three distinct genes (Vav1-Vav3). Unlike Vav1, which is exclusively expressed in hematopoietic cells, Vav2 and Vav3 are broadly expressed in embryonic and postnatal tissue 12, 13 . These two proteins are essential for proper signaling responses in cytoskeletal organization, mitogenesis, neuronal morphogenesis during development, and other biological processes 10, [13] [14] [15] . Vav proteins contain several subdomains, including Src-homology domains 2 and 3 (SH2 and SH3, respectively) and a guanine nucleotide releasing factor-like domain, each of which exhibits distinctive features. The SH2 and SH3 domains function as molecular adhesives linking cell surface receptor and downstream signaling proteins. The guanine nucleotide releasing factor-like domain can be quickly triggered by direct interaction with several ligand-activated transmembrane tyrosine kinases 10, 16 . Tyrosine phosphorylation of Vav triggers the activation of Vav GDP/GTP exchange a r t I C l e S activity that stimulates Rho and Rac GTPases 17 . Previous studies have shown that deficiency of Vav3 causes an increase in the concentration of plasma DA, whereas loss of Vav2 results in elevated plasma concentrations of noradrenaline and adrenaline 18, 19 . Given that Vav2 and 3 are expressed in developing and adult brain 10, 11, 15 and loss of Vav2 or Vav3 perturbs the balance of catecholamines in the peripheral sympathetic nervous system 18, 19 , we hypothesize that Vav proteins may also control steady-state levels of catecholamine in the brain.
In this study, we identify a Vav2-dependent mechanism for GDNF/Ret control of DAT trafficking as a crucial signaling pathway in the maintenance of DA homeostasis in the nucleus accumbens (NAc). We demonstrate that loss of Vav2 or Ret leads to an abnormal accumulation of DAT in the plasma membrane, resulting in disrupted DA homeostasis in DA neuron terminals and impaired behavioral response to cocaine. Our data indicate that Ret/Vav2 signaling is essential in regulating the mesolimbic DA system.
RESULTS

Midbrain Vav2 protein is preferentially found in adult VTA
Immunoblot analysis revealed a heterogeneous expression of Vav2 in adult mouse brain, with the highest levels in the ventral tegmental area (VTA) and olfactory bulb among the major brain regions examined, including the NAc, dorsal striatum (dSTR) and cerebral cortex (Fig. 1a,b) . To dissect these brain regions more precisely, we used transgenic mice expressing GFP under the control of the tyrosine hydroxylase (Th) promoter 20 . Vav2 expression was notably higher in the VTA than in the substantia nigra (SN) both at postnatal day (P) 14 and in the adult (Fig. 1c,d and Supplementary Fig. 1a,b) , whereas in the SN, Vav2 expression declined with age, consistent with developmental expression profile of Vav2 in whole brain lysates 10 .
Further western blotting analysis on the synaptosomes prepared from the NAc and dSTR showed that the levels of synaptosomal Vav2 protein in the NAc were 2.46-fold higher than in the dSTR (Vav2/DAT ratio: NAc, 0.90 ± 0.26; dSTR, 0.37 ± 0.07; n = 8 mice per group; unpaired two-tailed t-test, t 14 = 7.098, P < 0.0001) (Fig. 1e) . Vav2 in situ hybridization combined with immunohistochemistry for tyrosine hydroxylase (TH) performed on adult mouse brain sections showed that Vav2 hybridization signals were localized to TH + neurons in both the VTA and SN (Fig. 1f) . Some TH + neurons in both the VTA and SN pars compacta expressed Vav2 protein (Fig. 1g) . These results suggest that Vav2 displays a distinct expression pattern from Vav3 in brain (Supplementary Fig. 1c ) with preferential expression in VTA DA neurons.
Elevation of DA, but not noradrenaline and serotonin, in NAc of Vav2 −/− mice To unravel the potential function of Vav2 in the DA neuron systems, we measured monoamine concentrations in the NAc and dSTR of adult mice using high-performance liquid chromatography (HPLC). The levels of DA, but not of noradrenaline and serotonin, in the NAc of Vav2 −/− mice were markedly elevated (~150%) compared with those in their wild-type (WT) counterparts, whereas levels of the DA metabolites 3,4-dihydroxyphenylacetic acid (DOPAC) and homovanillic acid and the serotonin metabolite 5-hydroxyindoleacetic acid remained unchanged (Fig. 1h) . This may be an indication that the mutation has no influence on DA release, which would likely result in a parallel increase in DOPAC. However, the alteration of DA levels was not seen in the dSTR or olfactory bulb of Vav2 −/− mice ( Fig. 1i and Supplementary Fig. 1d ). Likewise, ablation of Vav3 did not result in a marked alteration in the concentrations of monoamines in both the NAc and dSTR (Supplementary Fig. 1e,f) . No significant morphological alteration in the mesolimbic and mesostriatal pathways in Vav2 −/− mice was observed ( Supplementary Fig. 1g,h ). Taken together, these results suggest that Vav2 is required for the maintenance of DA homeostasis in limbic DA neuron terminals in a brain region-specific manner.
DAT influences both extracellular clearance of DA and steadystate tissue levels of DA 21 . We thus first evaluated the effect of Vav2 ablation on the DA uptake. [ 3 H]DA radioassay revealed that genetic deletion of Vav2 resulted in an ~60% increase of DAT-mediated DA uptake in synaptosomal preparations from the NAc, but not from the dSTR. This effect could be rescued by adeno-associated virus (AAV)-mediated overexpression of Vav2 selectively in the VTA, but not SN (Fig. 2a,b and Supplementary Fig. 1i ). In contrast, Vav3 ablation had no effect on DAT activity (Supplementary Fig. 1j) . Similarly, either knockdown of Vav2 or overexpression of a GFP-Vav2 L212Q mutant, which has dominant negative Vav2 GEF activity 22 , caused an increase in [ 3 H]DA reuptake in human embryo kidney (HEK)-293 cell line stably expressing YFP-tagged DAT ( Fig. 2c and Supplementary Fig. 1k) . Moreover, knockdown of Vav2 caused the same effect in the Neuro 2A (N2a) mouse neural crest-derived cell line stably expressing both red fluorescent protein (RFP)-tagged DAT and GDNF co-receptor GFRα1 (Fig. 2d,e) , and this effect could be rescued by co-expression npg a r t I C l e S of RFP-tagged human Vav2 (Fig. 2e) . These results collectively support the idea that Vav2 functions as a negative regulator of DAT activity in a GEF activity-dependent manner. Further biochemical analysis showed normal degradation of DA with reduced DA biosynthesis in the absence of Vav2 ( Supplementary Fig. 2a-l) , which may result from negative feedback inhibition by the aberrantly high DA levels.
Vav2 negatively regulates DAT surface expression
The upregulation of DAT transporter activity in Vav2 −/− mice suggests enhanced surface expression of DAT. To test this, synaptosomes from both genotypes were biotinylated and immunoblotted using DAT-specific antibody. Levels of biotinylated DAT were markedly higher (~70%) in the NAc of Vav2 −/− mice relative to WT mice, while dSTR surface DAT expression showed no significant differences between genotypes (Fig. 2f,g ). In either case, the total DAT levels remained the same between genotypes (Supplementary Fig. 3a) . Likewise, in HEK293 cells, either knockdown or overexpression of Vav2 or a constitutive active mutant (Vav2 Y172F) also markedly altered DAT surface expression (Fig. 2h,i ), but not total DAT levels ( Supplementary Fig. 3b ,c). Consistent with these results, the maximal velocity (V max ) of These results suggest that the synaptosomal DAT transporter activity is largely regulated by Vav2-mediated membrane trafficking. Synaptosomal DAT activity is regulated by phosphorylation of DAT 23, 24 in addition to membrane trafficking [25] [26] [27] . To clarify the contribution of DAT phosphorylation to Vav2-mediated DAT regulation, we analyzed DAT phosphorylation using a Thr53-phosphospecific antibody, since the Thr53 DAT phosphorylation site regulates substrate reuptake and amphetamine-stimulated efflux 28 . Thr53 phosphorylation of DAT in the NAc, dSTR and VTA showed no significant differences between genotypes (Supplementary Fig. 2m,n) , supporting the idea that DAT phosphorylation at this site is not involved in Vav2-mediated DAT trafficking.
Vav2 is a substrate of Ret receptor tyrosine kinase Next we sought to determine the mechanisms by which Vav2 is activated in the regulation of DAT function. Recent studies have shown selective enhancement of DAT activity in the NAc of Gdnf +/− mice 29 , which resembles the phenotypes observed in Vav2 −/− mice (Fig. 2) . This led us to hypothesize that Vav2 may be functionally related to GDNF signaling. To test the hypothesis, we first assessed the DA tissue levels and DAT activity in Ret +/− mice, since Ret is a cognate receptor for GDNF with transmembrane tyrosine receptor kinase (RTK) activity 30 . In accordance with the biochemical changes observed in Vav2 −/− mice, there were significant increases in DA uptake in the synaptosomes from the ventral, but not dorsal, striatum of Ret +/− mice (Fig. 3a) . This was accompanied by a significant increase in DAT surface expression (Fig. 3b,c) , whereas total DAT levels were not significantly altered (Supplementary Fig. 3d ). We also found selective augmentation of tissue DA levels in the NAc, but not dSTR or olfactory bulb, of Ret +/− mice (Fig. 3d,e and Supplementary Fig. 4a) .
Consistent with the result that the levels of phospho-Thr53-DAT were not significantly different between genotypes in various brain regions ( Supplementary Fig. 2m,n) , Ret +/− mice also showed no marked alteration in the levels of phospho-Thr53 DAT expression ( Supplementary Fig. 4b,c) .
The evidence of a functional link between Vav2 and Ret suggests that the two proteins may function together in a complex to regulate limbic DAT activity. A yeast two-hybrid assay revealed that Vav2 bound to the intracellular domain (ICD) of Ret, whereas Vav3 interacted much more weakly with the Ret ICD than Vav2 in yeast cells ( Fig. 3f and Supplementary Fig. 5a ). Coimmunoprecipitation assays confirmed that there was no interaction between Vav3 and full-length Ret in HEK293 cells (Supplementary Fig. 5b) . Moreover, we identified a fragment of Vav2 that mediates the interaction between Vav2 and Ret. Among a series of deletion mutants of Vav2, the C-terminal SH2 domain of Vav2 was the minimal fragment for direct interaction between Vav2 and Ret (Fig. 3f) . Glutathione S-transferase (GST) pulldown or coimmunoprecipitation assay confirmed the observation that Vav2, through its adaptor domain, interacted with phosphorylated fulllength Ret (Fig. 3g,h) . Moreover, the binding between full-length Ret and Vav2 (Fig. 3h) or the Vav2 adaptor domain (Fig. 3g) depended on Ret phosphorylation(s), as inhibition of Ret kinase using the inhibitor 4-amino-5-(4-chlorophenyl)-7-(t-butyl)pyrazolo [3,4-d] pyramidine (PP2), but not its negative control 4-amino-7-phenylpyrazolo [3,4-d] pyramidine (PP3) 31 , drastically suppressed the phosphorylation of Vav2 and the interaction between phospho-Vav2 and phospho-Ret in HEK293 cells (Fig. 3h) . Similarly, coexpression of Vav2 and Ret resulted in enhanced phosphorylation of Vav2 tyrosine residue(s), which was also abrogated by PP2 only (Fig. 3h) .
Tyrosine phosphorylation of Ret is crucial for activation of downstream signaling 30 . We next sought to identify the tyrosine residues of Ret that are responsible for Vav2 activation by using a yeast two-hybrid npg a r t I C l e S assay. We individually replaced each of the sixteen tyrosine residues in the Ret ICD, which have been reported to be phosphorylated following GDNF stimulation 32 , with phenylalanine. Of the sixteen Ret mutants examined, only the Y905F mutant failed to interact with Vav2 (Fig. 3i) . GST pulldown and coimmunoprecipitation assays confirmed that mutation of Y905F markedly reduced Ret binding to Vav2 (Fig. 3j,k) , suggesting that Vav2 interacts specifically with the GDNF-activated form of the Ret. Taken together, these data suggest that Vav2 binds phosphorylated Ret and is a substrate of the Ret receptor tyrosine kinase.
Vav2 is recruited into GDNF/Ret signaling to regulate DAT function Next, we evaluated the impact of Ret/Vav2 signaling on the modulation of DAT function. To investigate whether Vav2 is required for Ret-mediated DAT regulation, we performed short hairpin RNA-mediated Vav2 knockdown in HEK293 cells stably expressing YFP-DAT. Ret overexpression-induced suppression of DA uptake was markedly relieved by shRNA-mediated knockdown of Vav2 (Fig. 4a) . In contrast, TrkA, a tyrosine receptor kinase that was reported to activate Vav1 in immune systems 33 , did not significantly alter DAT transporter activity (P = 0.1616; Supplementary Fig. 5c ).
We then determined whether GDNF functions via Ret/Vav2 signaling to directly regulate DAT activity. Exposure to GDNF of the human neuroblastoma SH-SY5Y cell line, which expresses GDNF receptors and Vav2, increased Vav2 tyrosine phosphorylation(s) and promoted Ret-Vav2 interaction (Fig. 4b,c) , suggesting that the Ret/Vav2 signaling is biochemically activated by GDNF. Augmentation of GDNF/Ret signaling by treatment with GDNF of N2a cells stably expressing RFPtagged human DAT and the GDNF co-receptor GFRα1 resulted in a marked reduction in DA uptake as revealed by [ 3 H]DA uptake assay (Fig. 4d) , suggesting that GDNF is a regulator for DAT activity, echoing a previous study demonstrating higher DAT activity in Gdnf +/− mice 29 . Treatment of N2a cells with GDNF or overexpression of Flag-tagged Ret in HEK293T cells also resulted in elevated Tyr905 phosphorylation of endogenous Ret (Supplementary Fig. 5d,e) , leading to decreased surface expression of Ret and DAT (relative ratio of surface DAT to total DAT: 30.72 ± 12.35%, n = 4; unpaired two-tailed t-test, t 6 = 5.612, P = 0.0014), but not total DAT, and this decrease was accompanied by decreased DA uptake ( Fig. 4e and Supplementary  Fig. 3e) . Notably, GDNF induced a much larger change in DAT surface levels than in DAT activity. Moreover, the GDNF-induced suppression of DAT transporter activity and DAT surface expression, but not total DAT levels, were markedly attenuated by shRNA knockdown of Vav2 (Fig. 4f,g and Supplementary Fig. 3f) .
PKC is known to be an important regulator for DAT trafficking and activity. We thus investigated the potential association between the GDNF/Vav2 signaling and PKC-mediated downregulation of DAT activity. In HEK293 cells, Vav2 knockdown partially blocked reduction in DA uptake by the PKC activator phorbol 12-myristate 13-acetate (PMA) (Supplementary Fig. 6a ), suggesting that PKC regulation of DAT is partially Vav2 dependent. Moreover, the GDNFinduced downregulation of DAT transporter activity in the N2a cells was not significantly attenuated by pretreatment with the PKC inhibitor GF109203X (P = 0.1695; Supplementary Fig. 6b ), suggesting that GDNF-regulated DAT activity is PKC independent. These data suggest GDNF/Ret signaling is a new type of DAT regulator, and their action on DAT activity is Vav2-dependent.
Binding between Ret and DAT is required for Ret/Vav2-dependent DAT trafficking Given that Ret/Vav2 was functionally associated with DAT (Figs. 2  and 3) , we speculated that Ret may interact with DAT in the plasma membrane, providing a molecular basis for Ret/Vav2-dependent DAT trafficking. To test this, we analyzed potential binding between Ret and DAT using the split-ubiquitin, membrane-based yeast twohybrid assay. Colony growth assays showed DAT-Cub-LexA-VP16 (where Cub is the C-terminal part of ubiquitin, amino acids 35-76) and Ret-NubG (ubiquitin N-terminal amino acids 1-34, with an I13G mutation) were expressed with no self-activation of the histidine reporter gene expression (Supplementary Fig. 7a) . Hence, we used the system to determine whether the two membrane proteins bind to each other. DAT did interact with Ret (Fig. 5a) , providing evidence consistent with a direct interaction. This result was confirmed by coimmunoprecipitation assay using tissue lysates from the NAc and dSTR (Fig. 5b,c) , as well as immunocytochemical staining showing colocalization of DAT and Ret in primary cultured mesencephalic neurons (Fig. 5d) . Moreover, activation of Ret enhanced binding between Vav2 and DAT as revealed by coimmunoprecipitation assays (Fig. 5e) . 
r t I C l e S
We also found that the binding between Ret and DAT was independent of Ret phosphorylation status, as PP2 treatment had no marked impact on the interaction between Ret and DAT in HEK293 cells (Supplementary Fig. 7b ), suggesting the Ret-DAT binding assumes a different nature from the Ret-Vav2 interaction, given that in the Ret-Vav2 interaction the phosphorylation of Ret is absolutely required (Fig. 2) . Also, coexpression of Ret and human DAT in HEK293 cells did not markedly alter Thr53 phosphorylation of DAT (Supplementary Fig. 7c ). These results further support the observation that GDNF/Ret/Vav2 signaling is vital for the regulation of DAT trafficking.
Vav2 is required for DAT trafficking in the context of cocaine
Previous studies have demonstrated that acute cocaine administration in rodents leads to elevated surface DAT expression and DAT activity 34, 35 . We hence examined whether Vav2 regulates DAT expression in response to cocaine. As expected, acute administration of cocaine resulted in a profound increase in levels of cell-surface, but not total, DAT in both the NAc and dSTR synaptosomes of WT mice as compared with saline-treated control (Fig. 6a-c and Supplementary  Fig. 3g,h ). This may be partially explained by impaired Ret/Vav2 signaling, as manifested by marked decreases in the binding between Vav2 and Ret (Fig. 6f) , which may allow more DAT protein to be released from the Ret/Vav2/DAT complex for its membrane accumulation. Similarly to the cocaine-evoked increases in DAT surface expression in WT animals, DAT surface expression levels were also elevated in the NAc, but not dSTR, of saline-treated Vav2 −/− mice. However, there was a dramatic decrease in the DAT surface expression and a trend toward the decrease in extracellular DA in the NAc of Vav2 −/− mice administered cocaine compared with cocainetreated WT mice (Fig. 6a-c and Supplementary Fig. 8a ), indicating that inactivation of Vav2 contributes to cocaine-induced abnormal distribution of limbic surface DAT, as well as perturbed synaptic cleft DA levels. Notably, a similar trend for DAT activity was found in cocaine-treated Vav2 −/− mice (Fig. 6d,e) . Furthermore, the cocaineinduced tissue DA increase in the NAc of WT mice was blocked in Vav2 −/− mice (Fig. 6g) , indicating that the DAT in Vav2 −/− mice failed to functionally response to cocaine stimulation. In contrast, Vav3 −/− mice and their WT counterparts displayed similar tissue DA levels following cocaine administration (Fig. 6h) . These results suggest that cocaine exposure impairs the Ret/Vav2 signaling pathway, leading to dysregulated DAT function and unbalanced DA homeostasis in limbic DA neuron terminals.
To assess the impact of Vav2-mediated DAT trafficking in the context of cocaine-induced addiction, we examined a series of behaviors in Vav2 −/− mice and controls. In tests of spontaneous activity, Vav2 −/− animals showed no marked difference in either novelty-associated locomotion over 30 min or in total locomotor activity patterns over npg a r t I C l e S 24 h when placed in a novel environment ( Fig. 7a and Supplementary  Fig. 8b ). Cocaine administered daily produced the expected increase in locomotor activity, and the magnitude of the response was larger on day 16 than on day 1, indicating the development of behavioral sensitization (Fig. 7b) . However, the response of Vav2 −/− , but not Vav3 −/− , mice was significantly blunted from day 3 onwards compared to that in WT mice after cocaine administration (Fig. 7b,c) . Consistent with these results, Vav2 −/− mice administered nomifensine, a norepinephrinedopamine reuptake inhibitor, showed reduced and delayed locomotor activity ( Supplementary Fig. 8b,c) . Moreover, the conditioned place preference (CPP) test revealed no preference evoked by low dose of cocaine (5 mg/kg) or significantly decreased preference (10 mg/kg cocaine) for the compartment paired with cocaine in Vav2 −/− mice, whereas cocaine at both 5 and 10 mg/kg induced robust CPP in WT mice (Fig. 7d) . This was not due to impaired learning and memory or to a difference in basal CPP, as there was no significant difference in performance in sucrose preference and contextual fear conditioning between genotypes (Supplementary Fig. 8e,f) . In comparison, Vav3 −/− mice did not display a profound change in CPP assay as compared with WT control (Supplementary Fig. 8g ). Vav2 −/− mice also exhibited normal response to the acoustic startle stimulation and prepulse inhibition (Supplementary Fig. 8h,i) . Notably, the attenuated cocaine-induced CPP and DAT activities in Vav2-deficient mice could be rescued by AAV-mediated Vav2 gene transfection selectively in the VTA (Fig. 7d,e) DISCUSSION Despite the importance of DAT under both the physiological and pathological conditions, little is known about how DAT trafficking is regulated in vivo and the functional contribution of these mechanisms to the maintenance of DA homeostasis in single DA neuron terminals in the brain. We found that Vav2-deficiency caused DAT hyperfunction, which was accompanied by an abnormal increase in intracellular DA preferentially in the NAc. Vav2 −/− mice showed reduced behavioral response to cocaine. Moreover, Vav2 interacted with Ret, forming a functional complex, and they cooperated to robustly downregulate DAT activity. These data confirm that Vav2-mediated DAT sequestration machinery plays a key role in the maintenance of DA homeostasis at DA neuron terminals in a brain region that is critical component of the neural circuitry involved in drug addiction. We found Vav2 to be required for the maintenance of DA homeostasis specifically in the mesolimbic system, as Vav2 is a VTAenriched protein in adult mouse brain and Vav2-or Ret-deficient mice exhibited increases in DA selectively in the NAc. In agreement with previous studies 36 , striatal DA levels were not perturbed in Ret +/− mice. Overexpression of Vav2 in the VTA attenuated Ret-deficiencyinduced DAT hyperfunction, demonstrating a causal relationship between the membrane DAT expression and Vav2 activation. These data thus provide a regulatory mechanism for the exquisite specificity of regulation of limbic DA homeostasis.
Previous studies suggest that Vav2 and Vav3 perform a similar function on many different occasions 10, 37 . However, we found here that Vav2 had distinct functions from those of Vav3 in the modulation of DA homeostasis in DA neuron terminals. In the brain, loss of Vav2, but not Vav3, resulted in marked elevation of intracellular DA (Fig. 1) . In contrast, in the peripheral sympathetic nervous system, deficiency of Vav3 or Vav2 causes perturbations in the concentrations of plasma catecholamines 18, 19 . These data demonstrate intriguing specialization of Vav family members in the nervous system. Vav2 and Vav3 participate the regulation of catecholamine levels of the central and peripheral nervous systems in a complementary manner, representing two mechanistically distinct molecular pathways used in the regulation of DA homeostasis at DA neuron terminals.
The present findings suggest a new mechanism of DAT functional regulation via Ret/Vav2 activation evoked by GDNF. Vav2 is believed to be involved in RTK signaling regulation of cell between WT first day and challenge day; t 15 = 1.314, P = 0.2086 between mutant first day and challenge day; t 26 = 3.585, P = 0.0014 for challenge day between genotypes. *P < 0.05 within subjects between the first and last days. (c) n = 8 for WT saline, n = 8 for WT cocaine, n = 9 for mutant saline, n = 10 for mutant cocaine. t 7 = 3.782, P = 0.0069 between WT first day and challenge day, t 9 = 4.755, P = 0.0010 between mutant first day and challenge day, t 16 = 0.2062, P = 0.8392 for challenge day between genotypes. (d) CPP test performance in Vav2 −/− and WT mice that received acute cocaine (5 or 10 mg/kg) and/or bilateral injection of AAV-GFP or AAV-Vav2 in the VTA. Two-way ANOVA with Sidak's post test for WT and mutants: main effect of genotype (F 1,53 = 11.14, P = 0.0015) and treatment (F 2,53 = 13.48, P < 0.0001), no effect of interaction (F 2,53 = 3.082, P = 0.0542); post hoc: **P = 0.0031 between mutant (n = 8 mice) and WT (n = 10 mice) treated with 5 mg/kg cocaine; F 1,53 = 11.14, *P = 0.0457 between mutant (n = 12 mice) and WT (n = 12 mice) treated with 10 mg/kg cocaine. For AAV-transfected animals, unpaired two-tailed t-test, t 16 npg a r t I C l e S differentiation and outgrowth during brain development 10, 11 . Activation of a RTK would normally cause the receptor itself to be downregulated by phosphorylation and internalization, thus terminating the signaling from the growth factor 10, 16 . We speculate that Vav2 mediates concomitant internalization of both DAT and RTK in response to GDNF treatment. The physical binding between DAT and Ret may facilitate their co-internalization. This is supported by previous findings that both Ret and DAT are localized to membrane microdomains, also known as lipid rafts 38, 39 . How might Vav2 modulate DAT function? A likely scenario is that tight binding between DAT and Ret allows their redistribution from the cell plasma membrane domains into endosomes. During this process, Vav2 is phosphorylated and subsequently recruited to the Ret-DAT complex through interacting with phospho-Tyr905-Ret. Vav2 then may activate the Rho small GTPase by catalyzing the exchange of GDP for GTP, contributing to endocytosis. Thus, Vav2 functions here in a way that is distinct from those shown in previous studies, where Vav2 mediates internalization of RTKs themselves (for example, Eph, TrkB), contributing to brain development 10, 40 . Taken together, our findings reveal a previously unrecognized role of Ret/Vav2 signaling in regulating DAT membrane expression and DA homeostasis in DA neuron terminals (Supplementary Fig. 9 ). It is worth noting that although coimmunoprecipitation assays showed interaction between exogenous DAT and Vav2 in cell lines, DAT was not immunoprecipitated with Vav2 in VTA tissue lysates from adult mouse brain (data not shown).
It has been widely accepted that psychostimulants and natural rewards have the mesolimbic DA system as a common substrate. Cocaine dramatically increases DAT surface expression in mammals 34, 41 , although the underlying molecular mechanisms remain elusive. There are two ways Vav2 may contribute to this process. First, the reduction evoked by cocaine in the binding between Ret and Vav2 suggests the impairment of Ret/Vav2 signaling, which may allow more DAT protein to be released from the Ret/Vav2 complex in the tubulovesicular structure for its membrane accumulation. Second, Vav2 may be required for DAT endosomal trafficking in the context of cocaine (Fig. 6) . Moreover, it is known that the ability to rapidly upregulate DAT function in response to acute cocaine is highly correlated with cocaine-induced locomotion 42 . In the present study, following acute exposure to cocaine, Vav2 −/− mice showed reduced DAT activity and surface expression in the NAc, which markedly compromised their ability to rapidly elevate DAT function and ultimately contributed to their lower cocaine-induced locomotor activation. On the basis of these results, we hypothesize that Vav2 is an important player in the signaling pathways that are altered in response to cocaine.
METHODS
Methods and any associated references are available in the online version of the paper. a r t I C l e S by subtracting the nonspecific uptake from the total radioactivity. For the kinetic assay, 30-50 µg fresh synaptosomes were incubated with 2.5 -180 nM [ 3 H]DA at 25 °C for 10 min in a total volume of 0.5 ml of uptake buffer. Kinetic parameters were determined by nonlinear regression fitting using Prism software (GraphPad Prism). V max and K m values for DA uptake were obtained using the generalized Michaelis-Menten equation (GraphPad Prism). The experimenter was blinded to the conditions during the analysis stage. mesencephalic neuronal culture. Primary VM neuronal cultures were prepared as described previously 53 . GDNF was added on the last day and incubated for 30 min before the cultures were analyzed for DAT-mediated DA uptake or DAT internalization.
In vivo microdialysis. In vivo microdialysis was performed as described previously 54 . Briefly, at approximately 10 a.m. on the experiment day, a microdialysis probe (CMA/7, 1.0-mm membrane, o.d. 0.24 mm) was inserted into the guide cannula that was placed at a point above the nucleus accumbens (A/P, +1.5 mm; L/M, +0.9 mm; D/V, 4.0 mm) according to a stereotaxic atlas 55 . The probe was infused with a modified Ringer solution at a flow rate of 1 µl/min for 1 or 2 h. The positions of the probes in the brains were verified histologically at the end of experiment. monoamine measurement using HPlc. The concentrations of dopamine, noradrenaline and their metabolites in microdialysis perfusates were determined by HPLC with an electrochemical detector as previously described 47 . The experimenter was blinded to the conditions during the analysis stage. To measure accumulated l-DOPA, mice were administered 100 mg/kg NSD-1015 (SigmaAldrich, i.p.) and NAc tissue punches were taken 30 min later.
Vav2 knockdown. shRNA targeting human, rat and mouse Vav2 (designated ShVav2 #1) was a gift from D.D. Billadeau (Mayo Clinic, USA) 56 . The sequences were as follows: shVav2 #1, 5′-GGACATTGAGAAGAACTAC-3′; scrambled shRNA, 5′-GACGAAGCCGAAAGTTTAA-3′. An shRNA specifically targeting mouse Vav2 was also designed and was designated shVav2 #2. The sequences were as follows: shVav2 #2, 5′-GACAAATTTGGACTAAGAA-3′, scrambled shRNA, 5′-GCAATTAGTGAATAGACAA-3′. They were cloned into pSicoR vector to generate pSicoR-shVav2 and pSicoR-scrambled as previously described 57 .
constructs, in vitro packaging of AAV-Vav2 and stereotactic injection. The mouse Vav2 cDNA was subcloned from pA1-flag-Vav2 constructs. The expression of Flag-tagged Vav2 is driven by the human synapsin 1 (hSyn; SYN1) gene promoter in these virus particles. The 2A signal peptide sequence was derived from plenti-2A-EGFP plasmid. The AAV2 backbone was cloned from pAAVhSyn-eNpAC-WPRE plasmid (gift from Z.L. Qiu). The AAV2 viruses were generated as previously described 58 . For viral injection in the brain in vivo, mice were anesthetized with pentobarbital sodium and placed in a stereotactic frame. Mice were injected bilaterally with 2 µl AAV virus (~10 13 infectious units per ml) into the VTA or SNc using glass microelectrodes. The animals were maintained for 5 weeks after surgery. RnA isolation and quantitative PcR. Isolation of total RNA and qPCR were performed as described previously 44 . Primers were designed using Primer Picking Program; their sequences were as follows: Vav2, forward, 5′-TGGA CTAAGAAACAGTGAGC-3′, reverse, 5′-TGTCTCCTCTGATGGAAATG-3′; MAO-A (Maoa), forward, 5′-AGTAGGCAGGATTTACTTTGCAG-3′, reverse, 5′-GCAACTTTTCCTAGAGCATTC-3′; MAO-B (Maob): forward, 5′-GAA GTTGAGCGGCTGATACAC-3′, reverse, 5′-GCATCACTGGGAATCTCTT GG-3′; β-actin (Actb), forward, 5′-GAGATTACTGCCCTGGCTCCTA-3′, reverse, 5′-TCATCGTACTCCTGCTTGCTGAT-3′.
Quantitative analysis of tH-positive fibers. The optical density of TH-immunoreactive terminals or processes of the NAc and dSTR of adult Vav2 −/− and WT mice was assessed as described previously 36 .
Behavior assays. Most behavioral tests began at approximately 10 a.m. All behavior assays were randomized and blind to the experimenter.
Spontaneous motor activity and motor response induced by drugs. Spontaneous locomotor activity in a 30-min or 24-h period was measured in an activity cage (45 × 45 cm) and analyzed by using a video tracking software package (EthoVision XT, Nodlus, Netherlands). Cumulative horizontal motor activity was recorded for 30 min or 90 min.
Eight-to 12-week-old male mice were administered cocaine (20 mg/kg, i.p.) or saline once a day for eight consecutive days. After each injection, mice were placed in 25 × 25 cm clear plastic cages equipped with AniLab Systems (China) for 1 h. On challenge day, mice were injected with cocaine (20 mg/kg) and placed back in the cage for 1 h. Locomotion was assessed as distance traveled for 1 h following each injection.
To evaluate motor effects induced by nomifensine, a DAT inhibitor, animals of each genotype were injected with 0.9% NaCl (0.01 ml/g body weight, i.p.) and placed into the activity boxes for 30 min period of habituation. After the habituation period, the mice were injected with nomifensine (10 mg/kg, i.p.) and placed into the same activity boxes for a 2-h recording period.
Conditioned place preference (CPP)
. CPP was tested in a rectangular Plexiglas shuttle box as described elsewhere 59 with a few modifications. Briefly, the apparatus consisted of three compartments, one with black walls and the other with white walls separated by a guillotine door. In the pretest (phase I), mice were allowed to explore the two compartments of the shuttle box for 15 min each day with the guillotine doors opened for 3 consecutive days. During the conditioning period (phase II, lasting the 8 d from day 2 to day 9), mice received four i.p. injections of saline and four of cocaine (5 or 10 mg/kg) at 24-h intervals. On odd training days (1, 3, 5 and 7), each mouse received saline i.p. and was immediately placed in the unpaired (black) compartment for 30 min. On even days (2, 4, 6 and 8) each mouse was injected i.p. with cocaine and was immediately placed in the cocaine-paired compartment, the white one, for 30 min. Control mice received saline only. On the test day (phase III, day 10), mice were individually placed at the intersection of the two compartments with free access to both sides. Neither cocaine nor vehicle was administered. The time spent in each compartment was recorded over 30 min. The increase in the time spent in the white compartment indicates reinforcing properties.
Contextual fear conditioning test. Contextual fear conditioning was carried out as described previously 60 with minor modifications. Briefly, mice were placed in a fear conditioning chamber (Med Associates, USA) and allowed to acclimate for 5 min. After the initial acclimation, mice received three foot shocks at 120, 152 and 184 s, using a low shock intensity of 0.5 mA constant current for 2 s. Mice were placed back in their home cages 2 min after the final foot shock. Freezing behavior was measured as the amount of time exhibiting freezing behavior during each intershock interval. To study contextual fear memory, mice were placed in the conditioned fear context 24 h after fear conditioning and reexposed to the context for 6 min without any foot shocks.
Sucrose preference test. The procedures for the sucrose preference test was similar to those described previously 61 . Briefly, mice were first singly housed and habituated with two bottles of water for 1 d. Then mice were water-deprived for 24 h and were then given a choice between two bottles, one with tap water and another with 3% sucrose solution, for 24 h. Total consumption of each fluid was measured and the sucrose preference was defined as the ratio of the consumption of sucrose solution versus the consumption of both water and sucrose solution during the test.
Accelerating rotarod test. A rotarod assay was done on a six-lane, belt-driven treadmill constructed for mice from Columbus Instruments as described previously 62 . Briefly, after acclimation to the instrument, mice were exercised until they were determined to be exhausted by their refusal to run despite short resting periods (<1-min rests on the platform) and gentle prodding with a tongue depressor. The rotarod started at a speed of 5 r.p.m. and progressed to 40 r.p.m. over a 5-min period. The mean latency to fall off the rotarod for the three trials was measured. Thirteen mice from each group were pretrained for the first day and recorded for the next 3 consecutive days. 
